MacroGenics, Inc. MGNX
| Analyst |
Entreprise |
Price during analysis |
Target price |
Potential gain |
Publication date |
| Peter Lawson |
Barclays |
1.59 $ |
3 $ |
1.41 % |
14/05/2025 |
| Stephen Willey |
Stifel Nicolaus |
3.38 $ |
6 $ |
2.62 % |
07/08/2024 |
| Silvan Tuerkcan |
JMP Securities |
5.25 $ |
8 $ |
2.75 % |
31/07/2024 |
| Mayank Mamtani |
B.Riley Financial |
5.25 $ |
5 $ |
-0.25 % |
31/07/2024 |
| Peter Lawson |
Barclays |
5.55 $ |
9 $ |
3.45 % |
29/07/2024 |
| Kaveri Pohlman |
BTIG |
4.63 $ |
9 $ |
4.37 % |
23/05/2024 |
| Debjit Chattopadhyay |
H.C. Wainwright |
4.3834 $ |
4 $ |
-0.38 % |
13/05/2024 |
| Peter Lawson |
Barclays |
14.67 $ |
14 $ |
-0.67 % |
10/05/2024 |
| Etzer Darout |
BMO Capital |
14.67 $ |
8 $ |
-6.67 % |
10/05/2024 |
| Stephen Willey |
Stifel Nicolaus |
13.67 $ |
29 $ |
15.33 % |
04/04/2024 |
| Charles Zhu |
Guggenheim |
6.18 $ |
12 $ |
5.82 % |
22/11/2022 |
| Kaveri Pohlman |
BTIG |
3.55 $ |
6 $ |
2.45 % |
11/07/2022 |
| David Nierengarten |
Wedbush |
20.86 $ |
32 $ |
11.14 % |
16/06/2021 |